Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-28

Clinical Trial Update: Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the short-term effect of a 2% atorvastatin dentifrice on periodontal status in chronic periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atorvastatin dentifrice (2%) (atorvastatin)

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Chronic Periodontitis | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28